These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 19567440)
1. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. Cahill KS; Chi JH; Day A; Claus EB JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440 [TBL] [Abstract][Full Text] [Related]
2. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011. Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905 [TBL] [Abstract][Full Text] [Related]
3. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008. Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827 [TBL] [Abstract][Full Text] [Related]
4. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein. Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577 [TBL] [Abstract][Full Text] [Related]
5. Morbid obesity increases cost and complication rates in spinal arthrodesis. Kalanithi PA; Arrigo R; Boakye M Spine (Phila Pa 1976); 2012 May; 37(11):982-8. PubMed ID: 22037526 [TBL] [Abstract][Full Text] [Related]
6. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein. Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI; Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187 [TBL] [Abstract][Full Text] [Related]
7. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges. Deyo RA; Ching A; Matsen L; Martin BI; Kreuter W; Jarvik JG; Angier H; Mirza SK Spine (Phila Pa 1976); 2012 Feb; 37(3):222-30. PubMed ID: 21494195 [TBL] [Abstract][Full Text] [Related]
8. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions. Goode AP; Richardson WJ; Schectman RM; Carey TS Spine J; 2014 Sep; 14(9):2051-9. PubMed ID: 24321129 [TBL] [Abstract][Full Text] [Related]
9. Does bone morphogenetic protein change the operative nonunion rates in spine fusions? Guppy KH; Paxton EW; Harris J; Alvarez J; Bernbeck J Spine (Phila Pa 1976); 2014 Oct; 39(22):1831-9. PubMed ID: 25299166 [TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for dysphagia after anterior cervical fusion. Singh K; Marquez-Lara A; Nandyala SV; Patel AA; Fineberg SJ Spine (Phila Pa 1976); 2013 Oct; 38(21):1820-5. PubMed ID: 23873236 [TBL] [Abstract][Full Text] [Related]
11. Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011. Marquez-Lara A; Nandyala SV; Fineberg SJ; Singh K Spine (Phila Pa 1976); 2014 Mar; 39(6):476-81. PubMed ID: 24365907 [TBL] [Abstract][Full Text] [Related]
12. The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database. Veeravagu A; Cole TS; Jiang B; Ratliff JK; Gidwani RA Spine J; 2014 Dec; 14(12):2929-37. PubMed ID: 24842396 [TBL] [Abstract][Full Text] [Related]
14. Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins. Yaremchuk KL; Toma MS; Somers ML; Peterson E Laryngoscope; 2010 Oct; 120(10):1954-7. PubMed ID: 20824786 [TBL] [Abstract][Full Text] [Related]
15. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery. Hofstetter CP; Hofer AS; Levi AD J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283 [TBL] [Abstract][Full Text] [Related]
16. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012. Martin BI; Lurie JD; Tosteson AN; Deyo RA; Farrokhi FR; Mirza SK Spine J; 2015 Apr; 15(4):692-9. PubMed ID: 25523380 [TBL] [Abstract][Full Text] [Related]
17. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database. Cole T; Veeravagu A; Jiang B; Ratliff JK J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578 [TBL] [Abstract][Full Text] [Related]
19. Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients. Guppy KH; Harris J; Chen J; Paxton EW; Alvarez J; Bernbeck J J Neurosurg Spine; 2016 Apr; 24(4):556-64. PubMed ID: 26722955 [TBL] [Abstract][Full Text] [Related]
20. The Incidence of Durotomy and its Clinical and Economic Impact in Primary, Short-segment Lumbar Fusion: An Analysis of 17,232 Cases. Buck JS; Yoon ST Spine (Phila Pa 1976); 2015 Sep; 40(18):1444-50. PubMed ID: 26426713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]